SCHEMBL6489161

SCHEMBL6489161

[CH2]c1cc(C2CC2)nc2ccccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.61
ALDH1A1 P00352 3/20 0.44
HPGD P15428 2/20 0.44
HTT P42858 1/20 0.44
CYP1A2 P05177 2/20 0.43
ALPL P05186 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
KMT2A Q03164 2/20 0.41
BCHE P06276 1/20 0.41
ACHE P22303 1/20 0.41
KDM4E B2RXH2 3/20 0.41
LMNA P02545 2/20 0.41
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
TP53 P04637 1/20 0.39
GAA P10253 1/20 0.39
HSD17B10 Q99714 2/20 0.39
NUDT1 P36639 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6489166 0.84 POLB (0.59) POLBALDH1A1HPGDHTTCYP1A2
SCHEMBL6479282 0.80 POLB (0.64) POLBALDH1A1HPGDHTTCYP1A2
SCHEMBL8355458 0.79 POLB (0.62) POLBALDH1A1HPGDHTTCYP1A2
SCHEMBL25523588 0.79 CYP1A2 (0.55) POLBALDH1A1HPGDHTTCYP1A2
SCHEMBL31732385 0.79 POLB (0.62) POLBALDH1A1HPGDHTTCYP1A2
SCHEMBL28284859 0.79 POLB (0.58) POLBALDH1A1HPGDHTTCYP1A2
SCHEMBL25523590 0.77 KDM4E (0.56) POLBALDH1A1HPGDHTTCYP1A2
SCHEMBL8355960 0.77 POLB (0.56) POLBALDH1A1HPGDHTTCYP1A2
SCHEMBL26934006 0.77 POLB (0.56) POLBALDH1A1HPGDHTTCYP1A2
SCHEMBL24506079 0.77 POLB (0.68) POLBALDH1A1CYP1A2ALPLCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962938-B2 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-11-08 US disclosed
US-6720329-B2 ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA 2004-04-13 US disclosed
EP-1373199-A4 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) BRISTOL MYERS SQUIBB PHARMA CO (US) 2004-04-07 EP disclosed
EP-1373199-A2 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) Bristol-Myers Squibb Pharma Company (US) 2004-01-02 EP disclosed
WO-2002074738-A2 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) BRISTOL-MYERS SQUIBB COMPANY (US) 2002-09-26 WO disclosed